| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6174524 | SANDOZ | Gelling ophthalmic compositions containing xanthan gum |
Mar, 2019
(5 years ago) | |
|
US6174524 (Pediatric) | SANDOZ | Gelling ophthalmic compositions containing xanthan gum |
Sep, 2019
(4 years ago) | |
Timolol Maleate is owned by Sandoz.
Timolol Maleate contains Timolol Maleate.
Timolol Maleate has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Timolol Maleate are:
- US6174524
- US6174524*PED
Timolol Maleate was authorised for market use on 21 October, 1998.
Timolol Maleate is available in solution, gel forming/drops;ophthalmic dosage forms.
The generics of Timolol Maleate are possible to be released after 26 September, 2019.
Drugs and Companies using TIMOLOL MALEATE ingredient
Market Authorisation Date: 21 October, 1998
Treatment: NA
Dosage: SOLUTION, GEL FORMING/DROPS;OPHTHALMIC
More Information on Dosage
TIMOLOL MALEATE family patents
